US Stock MarketDetailed Quotes

EVAX Evaxion Biotech

Watchlist
  • 1.220
  • -0.080-6.15%
Trading Dec 12 12:04 ET
7.16MMarket Cap-0.44P/E (TTM)

Evaxion Biotech Key Stats

Evaxion Biotech Q3 2024 Earnings Date

Currency:USDOct 31, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
0
3.02M
+3.02M
Beat Est.
--
--
--
EPS
--
-0.40
--
+80.95%
Buy

Nov 30, 2024

Evaxion Biotech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.200M--
--2024/Q4-- / 1.660M--
Oct 31, 20242024/Q33.017M / 0.000--
Aug 14, 20242024/Q2154.000K / 52.000K--
--2024/Q151.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.200M--
--2024/Q4-- / 1.660M--
Oct 31, 20242024/Q33.017M / 0.000--
Aug 14, 20242024/Q2154.000K / 52.000K--
--2024/Q151.000K / 0.000--

Unlock Free Earnings Estimates

Evaxion Biotech Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Nov 30, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data